280 related articles for article (PubMed ID: 25803810)
1. Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation.
Yamamoto K; Takahashi K; Shiozaki K; Yamaguchi K; Moriya S; Hosono M; Shima H; Miyagi T
PLoS One; 2015; 10(3):e0120578. PubMed ID: 25803810
[TBL] [Abstract][Full Text] [Related]
2. Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.
Takahashi K; Hosono M; Sato I; Hata K; Wada T; Yamaguchi K; Nitta K; Shima H; Miyagi T
Int J Cancer; 2015 Oct; 137(7):1560-73. PubMed ID: 25810027
[TBL] [Abstract][Full Text] [Related]
3. NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels.
Mozzi A; Forcella M; Riva A; Difrancesco C; Molinari F; Martin V; Papini N; Bernasconi B; Nonnis S; Tedeschi G; Mazzucchelli L; Monti E; Fusi P; Frattini M
Glycobiology; 2015 Aug; 25(8):855-68. PubMed ID: 25922362
[TBL] [Abstract][Full Text] [Related]
4. Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice.
Shiozaki K; Yamaguchi K; Sato I; Miyagi T
Cancer Sci; 2009 Apr; 100(4):588-94. PubMed ID: 19215228
[TBL] [Abstract][Full Text] [Related]
5. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells.
Wada T; Hata K; Yamaguchi K; Shiozaki K; Koseki K; Moriya S; Miyagi T
Oncogene; 2007 Apr; 26(17):2483-90. PubMed ID: 17334392
[TBL] [Abstract][Full Text] [Related]
6. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
7. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration.
Dise RS; Frey MR; Whitehead RH; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704
[TBL] [Abstract][Full Text] [Related]
9. NEU3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation.
Yoshinaga A; Kajiya N; Oishi K; Kamada Y; Ikeda A; Chigwechokha PK; Kibe T; Kishida M; Kishida S; Komatsu M; Shiozaki K
Eur J Pharmacol; 2016 Jul; 782():21-9. PubMed ID: 27105818
[TBL] [Abstract][Full Text] [Related]
10. Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling.
Kato K; Shiga K; Yamaguchi K; Hata K; Kobayashi T; Miyazaki K; Saijo S; Miyagi T
Biochem J; 2006 Mar; 394(Pt 3):647-56. PubMed ID: 16241905
[TBL] [Abstract][Full Text] [Related]
11. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-induced mobilization of a ganglioside-specific sialidase (NEU3) to membrane ruffles.
Yamaguchi K; Hata K; Wada T; Moriya S; Miyagi T
Biochem Biophys Res Commun; 2006 Jul; 346(2):484-90. PubMed ID: 16765317
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidic acid-mediated activation and translocation to the cell surface of sialidase NEU3, promoting signaling for cell migration.
Shiozaki K; Takahashi K; Hosono M; Yamaguchi K; Hata K; Shiozaki M; Bassi R; Prinetti A; Sonnino S; Nitta K; Miyagi T
FASEB J; 2015 May; 29(5):2099-111. PubMed ID: 25678627
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis.
Shiga K; Takahashi K; Sato I; Kato K; Saijo S; Moriya S; Hosono M; Miyagi T
Cancer Sci; 2015 Nov; 106(11):1544-53. PubMed ID: 26470851
[TBL] [Abstract][Full Text] [Related]
16. E3B1, a human homologue of the mouse gene product Abi-1, sensitizes activation of Rap1 in response to epidermal growth factor.
Jenei V; Andersson T; Jakus J; Dib K
Exp Cell Res; 2005 Nov; 310(2):463-73. PubMed ID: 16182283
[TBL] [Abstract][Full Text] [Related]
17. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
19. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility.
Ueno S; Saito S; Wada T; Yamaguchi K; Satoh M; Arai Y; Miyagi T
J Biol Chem; 2006 Mar; 281(12):7756-64. PubMed ID: 16428383
[TBL] [Abstract][Full Text] [Related]
20. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
